Figure 6
Five-year relative survival for node-positive cases within the St Gallen intermediate risk group (intermediate risk 3) according to the ER/PR/HER2 subtypes.
Figure 6 | BMC Cancer
Five-year relative survival for node-positive cases within the St Gallen intermediate risk group (intermediate risk 3) according to the ER/PR/HER2 subtypes.